Fireside chat in Rome: from a diagnosis to a gene therapy programme


April 2026


Video: Alliance for Regenerative Medicine. 28 minutes.

In April Sebastian was invited on stage at the Cell & Gene Meeting on the Med in Rome, the Alliance for Regenerative Medicine’s annual European conference for cell and gene therapies. In a fireside chat with Jason Foster, CEO of Ori Biotech, he told the story behind Cure Lowe Foundation.

He described Walther’s first months, and the day the family was told that nothing could be done beyond treating the symptoms. That evening he told Cecilie there had to be something they could do.

An economist by training, he studied drug development, gathered scientists and experts in regulation and manufacturing around the question, and together they built a gene therapy programme for the kidney from scratch. “It was either us or nothing,” he said.

The programme now sits in Walther Therapeutics, the company founded and owned by the foundation, which can raise the investment that clinical development requires.

His ask to the companies in the room:

Be bold and partner early. Programmes like this need the platforms and experience of established companies in the risky early phase, not only after a first trial in people.
Work together on regulatory pathways that fit very rare diseases.

He ended with a video of Walther, who had just started walking.

During the meeting Sebastian also took part in a panel discussion.

Watch on YouTube

All stories